Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Drugs ; 32(10): 1138-1141, 2021 11 01.
Article in English | MEDLINE | ID: mdl-34232947

ABSTRACT

In the present case study, we describe a 53-year-old male with an aggressive small cell lung cancer (SCLC) that was diagnosed in January 2019. Our patient was treated as first line of systemic chemotherapy consisting of cisplatin and etoposide followed by mediastinal prophylactic radiotherapy with good response later he received for his metastatic disease (M-SCLC) a rechallenge of systemic chemotherapy consisting of carboplatin, etoposide and dulvalumab with stable disease and after progression his disease he was treated with lurbinectedin and after four cycles he reached a complete radiologic response. To the best of our knowledge, this is the first case to be reported of M-SCLC patient treated with prior of two types of platinum combination with immunotherapy and reaching a complete radiologic response.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Chemoradiotherapy/methods , Lung Neoplasms/therapy , Small Cell Lung Carcinoma/therapy , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Platinum Compounds/therapeutic use , Small Cell Lung Carcinoma/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...